Chuan-Wei Tung, Kanchan Thapa, Anna Phan, Aditi Mohapatra, Muhammad Hashmi, Kayla Bleich, Debabrata Biswas
{"title":"融合内溶素ENDO-1252/KL9P对多种血清型肠沙门氏菌的抑菌活性","authors":"Chuan-Wei Tung, Kanchan Thapa, Anna Phan, Aditi Mohapatra, Muhammad Hashmi, Kayla Bleich, Debabrata Biswas","doi":"10.1111/1751-7915.70237","DOIUrl":null,"url":null,"abstract":"<p><i>Salmonella enterica</i> (SE) is one of the most prevalent enteric pathogens globally and infects humans through contaminated food and water sources. The rising trend of antibiotic-resistant SE strains poses a critical threat to public health. Bacteriophage-encoded endolysins evolve a promising alternative as antimicrobial agents for combating SE infections. These enzymes target the peptidoglycan layer of bacterial cells, causing cell lysis and death. However, the use of endolysins against Gram-negative bacteria is challenging due to the composition of the outer membrane, which acts as a barrier preventing the endolysins from reaching the peptidoglycan layer. KL9P is a short amphipathic peptide containing both hydrophobic and hydrophilic regions, enabling it to interact with membranes and aqueous environments. In this study, an endolysin ENDO-1252, a <i>Salmonella</i> bacteriophage-encoded enzyme, was fused with a short peptide KL9P and produced an advanced endolysin, ENDO-1252/KL9P, which enhanced its ability to lyse multiple serovars of SE. ENDO-1252/KL9P exhibited potent lytic activity against SE strains with optimal bactericidal effects observed at 20 μM and incubation at 37°C in 20 mM HEPES buffer (pH 7.4). The lytic activity of this endolysin was also evaluated under various conditions, including pH ranges and temperatures, revealing that ENDO-1252/KL9P retained significant lytic activity across a range of temperatures (25°C–40°C) and pH values (6.0–9.0). The fusion protein demonstrated the highest lytic efficiency against SE serovars, specifically <i>S.</i> Enteritidis, <i>S.</i> Heidelberg, and <i>S.</i> Pullorum. Immunofluorescence analysis confirmed the binding of ENDO-1252/KL9P to the bacterial cell wall, indicating the co-localization with the peptidoglycan layer. These results suggest that ENDO-1252/KL9P is a promising antibacterial agent inhibiting predominant serovars of SE, showing enhanced lytic activity without outer membrane permeabilizers.</p>","PeriodicalId":209,"journal":{"name":"Microbial Biotechnology","volume":"18 10","pages":""},"PeriodicalIF":5.2000,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://enviromicro-journals.onlinelibrary.wiley.com/doi/epdf/10.1111/1751-7915.70237","citationCount":"0","resultStr":"{\"title\":\"Antibacterial Activity of a Fused Endolysin ENDO-1252/KL9P Against Multiple Serovars of Salmonella enterica\",\"authors\":\"Chuan-Wei Tung, Kanchan Thapa, Anna Phan, Aditi Mohapatra, Muhammad Hashmi, Kayla Bleich, Debabrata Biswas\",\"doi\":\"10.1111/1751-7915.70237\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><i>Salmonella enterica</i> (SE) is one of the most prevalent enteric pathogens globally and infects humans through contaminated food and water sources. The rising trend of antibiotic-resistant SE strains poses a critical threat to public health. Bacteriophage-encoded endolysins evolve a promising alternative as antimicrobial agents for combating SE infections. These enzymes target the peptidoglycan layer of bacterial cells, causing cell lysis and death. However, the use of endolysins against Gram-negative bacteria is challenging due to the composition of the outer membrane, which acts as a barrier preventing the endolysins from reaching the peptidoglycan layer. KL9P is a short amphipathic peptide containing both hydrophobic and hydrophilic regions, enabling it to interact with membranes and aqueous environments. In this study, an endolysin ENDO-1252, a <i>Salmonella</i> bacteriophage-encoded enzyme, was fused with a short peptide KL9P and produced an advanced endolysin, ENDO-1252/KL9P, which enhanced its ability to lyse multiple serovars of SE. ENDO-1252/KL9P exhibited potent lytic activity against SE strains with optimal bactericidal effects observed at 20 μM and incubation at 37°C in 20 mM HEPES buffer (pH 7.4). The lytic activity of this endolysin was also evaluated under various conditions, including pH ranges and temperatures, revealing that ENDO-1252/KL9P retained significant lytic activity across a range of temperatures (25°C–40°C) and pH values (6.0–9.0). The fusion protein demonstrated the highest lytic efficiency against SE serovars, specifically <i>S.</i> Enteritidis, <i>S.</i> Heidelberg, and <i>S.</i> Pullorum. Immunofluorescence analysis confirmed the binding of ENDO-1252/KL9P to the bacterial cell wall, indicating the co-localization with the peptidoglycan layer. These results suggest that ENDO-1252/KL9P is a promising antibacterial agent inhibiting predominant serovars of SE, showing enhanced lytic activity without outer membrane permeabilizers.</p>\",\"PeriodicalId\":209,\"journal\":{\"name\":\"Microbial Biotechnology\",\"volume\":\"18 10\",\"pages\":\"\"},\"PeriodicalIF\":5.2000,\"publicationDate\":\"2025-10-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://enviromicro-journals.onlinelibrary.wiley.com/doi/epdf/10.1111/1751-7915.70237\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Microbial Biotechnology\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://enviromicro-journals.onlinelibrary.wiley.com/doi/10.1111/1751-7915.70237\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbial Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://enviromicro-journals.onlinelibrary.wiley.com/doi/10.1111/1751-7915.70237","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
肠沙门氏菌是全球最常见的肠道病原体之一,通过受污染的食物和水源感染人类。耐抗生素SE菌株呈上升趋势,对公共卫生构成严重威胁。噬菌体编码的内溶素是对抗SE感染的一种有前途的抗菌药物。这些酶以细菌细胞的肽聚糖层为目标,导致细胞裂解和死亡。然而,由于外膜的组成,使用内溶素对抗革兰氏阴性菌是具有挑战性的,它作为一个屏障,阻止内溶素到达肽聚糖层。KL9P是一种短的两亲肽,包含疏水和亲水区域,使其能够与膜和水环境相互作用。在本研究中,沙门氏菌噬菌体编码酶ENDO-1252与短肽KL9P融合,产生一种高级内溶素ENDO-1252/KL9P,增强了其裂解多种血清型SE的能力。ENDO-1252/KL9P对SE菌株具有较强的裂解活性,在20 μM条件下,37°C 20 mM HEPES缓冲液(pH 7.4)中杀菌效果最佳。在不同的条件下,包括pH范围和温度,对这种内溶素的裂解活性进行了评估,结果表明ENDO-1252/KL9P在温度(25°C-40°C)和pH值(6.0-9.0)范围内保持了显著的裂解活性。该融合蛋白对大肠杆菌血清型,特别是肠炎沙门氏菌、海德堡沙门氏菌和白痢沙门氏菌具有最高的裂解效率。免疫荧光分析证实ENDO-1252/KL9P与细菌细胞壁结合,表明其与肽聚糖层共定位。这些结果表明,ENDO-1252/KL9P是一种很有前景的抗菌药物,可以抑制主要的SE血清型,在没有外膜渗透剂的情况下表现出增强的裂解活性。
Antibacterial Activity of a Fused Endolysin ENDO-1252/KL9P Against Multiple Serovars of Salmonella enterica
Salmonella enterica (SE) is one of the most prevalent enteric pathogens globally and infects humans through contaminated food and water sources. The rising trend of antibiotic-resistant SE strains poses a critical threat to public health. Bacteriophage-encoded endolysins evolve a promising alternative as antimicrobial agents for combating SE infections. These enzymes target the peptidoglycan layer of bacterial cells, causing cell lysis and death. However, the use of endolysins against Gram-negative bacteria is challenging due to the composition of the outer membrane, which acts as a barrier preventing the endolysins from reaching the peptidoglycan layer. KL9P is a short amphipathic peptide containing both hydrophobic and hydrophilic regions, enabling it to interact with membranes and aqueous environments. In this study, an endolysin ENDO-1252, a Salmonella bacteriophage-encoded enzyme, was fused with a short peptide KL9P and produced an advanced endolysin, ENDO-1252/KL9P, which enhanced its ability to lyse multiple serovars of SE. ENDO-1252/KL9P exhibited potent lytic activity against SE strains with optimal bactericidal effects observed at 20 μM and incubation at 37°C in 20 mM HEPES buffer (pH 7.4). The lytic activity of this endolysin was also evaluated under various conditions, including pH ranges and temperatures, revealing that ENDO-1252/KL9P retained significant lytic activity across a range of temperatures (25°C–40°C) and pH values (6.0–9.0). The fusion protein demonstrated the highest lytic efficiency against SE serovars, specifically S. Enteritidis, S. Heidelberg, and S. Pullorum. Immunofluorescence analysis confirmed the binding of ENDO-1252/KL9P to the bacterial cell wall, indicating the co-localization with the peptidoglycan layer. These results suggest that ENDO-1252/KL9P is a promising antibacterial agent inhibiting predominant serovars of SE, showing enhanced lytic activity without outer membrane permeabilizers.
期刊介绍:
Microbial Biotechnology publishes papers of original research reporting significant advances in any aspect of microbial applications, including, but not limited to biotechnologies related to: Green chemistry; Primary metabolites; Food, beverages and supplements; Secondary metabolites and natural products; Pharmaceuticals; Diagnostics; Agriculture; Bioenergy; Biomining, including oil recovery and processing; Bioremediation; Biopolymers, biomaterials; Bionanotechnology; Biosurfactants and bioemulsifiers; Compatible solutes and bioprotectants; Biosensors, monitoring systems, quantitative microbial risk assessment; Technology development; Protein engineering; Functional genomics; Metabolic engineering; Metabolic design; Systems analysis, modelling; Process engineering; Biologically-based analytical methods; Microbially-based strategies in public health; Microbially-based strategies to influence global processes